Perrigo requests 18-month extension of PPA warning label effective date.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO REQUESTS PPA LABEL-WARNING EXTENSION from the six-month period proposed by FDA to an 18-month period in May 13 comments to the agency. FDA, in a Feb. 14 Federal Register notice, proposed new warning labeling requirements for all OTC drugs containing phenylpropanolamine (PPA) ("The Tan Sheet" Feb. 19, p. 9).